Orlistat
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
FADB-China ID | C0484 |
Substance Name | Antiobesity drug |
Substance Chinese Name | 减肥药 |
Molecular Name | Orlistat |
Molecular Chinese Name | 奥利司他 |
2D Structure | |
CAS Number | 96829-58-2 |
PubChem CID | 3034010 |
Formula | C29H53NO5 |
IUPAC Name | [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate |
InChI Key | AHLBNYSZXLDEJQ-FWEHEUNISA-N |
InChI | InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1 |
Canonical SMILES | CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O |
Isomeric SMILES | CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O |
CFM-ID 3.0 | URL Link |
Related links | Processing |
Addition Purposes | Enhance health care function |
Molecular Synonyms | Orlistat 96829-58-2 Tetrahydrolipstatin Xenical Alli Orlipastat Orlipastatum Orlipastatum [INN-Latin] THLP (-)-Tetrahydrolipstatin |
Data Uploader | Shuyu Ouyang |
Update Date | Jul 25, 2019 20:46 |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 495.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 23 |
Complexity | 579 |
Monoisotopic Mass | 495.39237381 |
Exact Mass | 495.39237381 |
XLogP | 10 |
Formal Charge | 0 |
Heavy Atom Count | 35 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.5923 |
Human Intestinal Absorption | HIA+ | 0.9728 |
Caco-2 Permeability | Caco2- | 0.5611 |
P-glycoprotein Substrate | Substrate | 0.5411 |
P-glycoprotein Inhibitor | Inhibitor | 0.6242 |
Inhibitor | 0.5301 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9097 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5522 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8540 |
CYP450 2D6 Substrate | Non-substrate | 0.8260 |
CYP450 3A4 Substrate | Substrate | 0.5867 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8458 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8305 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8869 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7315 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9070 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9671 |
Non-inhibitor | 0.9395 | |
AMES Toxicity | Non AMES toxic | 0.7333 |
Carcinogens | Non-carcinogens | 0.8628 |
Fish Toxicity | High FHMT | 0.7375 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9931 |
Honey Bee Toxicity | High HBT | 0.5259 |
Biodegradation | Not ready biodegradable | 0.7808 |
Acute Oral Toxicity | III | 0.6614 |
Carcinogenicity (Three-class) | Non-required | 0.6317 |
ADMET -- Regression
Model | Value | Unit |
---|---|---|
Aqueous solubility | -3.1463 | LogS |
Caco-2 Permeability | 0.4620 | LogPapp, cm/s |
Rat Acute Toxicity | 2.3363 | LD50, mol/kg |
Fish Toxicity | 1.0874 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.4626 | pIGC50, ug/L |
Related Foods
FADB-China ID | F0142 |
Food Image | ![]() |
Food Name | Plant food supplements |
Food Chinese Name | 植物食品补充剂 |
Food Type | Processed food |
References | Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review |